Balaxi Pharmaceuticals shareholding pattern
BALAXI
41.12
0.82 (-1.96%)Last updated on 17 Oct, 2025 | 15:46 IST
BUYSELL
The current prices are delayed, login to your account for live prices
LoginBalaxi Pharmaceuticals FAQs
As of 10-2025, the promoter shareholding in Balaxi Pharmaceuticals stands at 65.99% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Balaxi Pharmaceuticals is 8.86% and 0.03% respectively.
The retail shareholding of the Balaxi Pharmaceuticals is 25.12%.
Changes in shareholding patterns of Balaxi Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Balaxi Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.